Artificial Intelligence Clinical Genomics Interpretation Market Growth Forecast: Market Size, Key Trends And Emerging Opportunities Through 2030
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Artificial Intelligence Clinical Genomics Interpretation Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The artificial intelligence clinical genomics interpretation market size has experienced significant expansion in recent years. This market is projected to expand from $1.74 billion in 2025 to $2.23 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 28.3%. Factors contributing to this historical growth include the rising availability of genomic sequencing data, the broadening of precision medicine initiatives, enhanced adoption of bioinformatics platforms, the increasing clinical application of genomic insights, and the early integration of AI into genomics workflows.
The artificial intelligence clinical genomics interpretation market size is expected to experience substantial growth in the coming years. It is projected to expand to $5.99 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 28.0%. This expansion during the forecast period is driven by factors such as the increasing demand for personalized healthcare solutions, rising investments in genomic data analytics, the broadening of oncology-focused genomics applications, the growing adoption of cloud-based interpretation platforms, and an increasing focus on clinical-grade genomic reporting. Major trends anticipated in this period include the increasing adoption of AI-based variant interpretation tools, a rising integration of genomics with clinical decision support, the growing use of predictive modeling in genomic analysis, the expansion of cloud-based genomics platforms, and an enhanced focus on personalized treatment planning.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Intelligence Clinical Genomics Interpretation Market Demand Drivers: What’s Powering Industry Growth?
The expanding need for personalized medicine is anticipated to fuel the future expansion of the artificial intelligence clinical genomics interpretation market. This medical strategy involves customizing diagnostic, therapeutic, and preventive methods based on a person’s unique genetic makeup, environmental influences, and lifestyle choices. The heightened interest in personalized medicine stems from its capacity for more efficacious treatments, since therapies are adapted to an individual’s genetic profile, leading to better results and fewer negative reactions. Artificial intelligence clinical genomics interpretation supports the demand for personalized medicine by swiftly processing intricate genomic data to pinpoint accurate, patient-specific treatment solutions, thereby enhancing therapeutic efficacy and minimizing experimental approaches. A notable example is from February 2024, when the Personalized Medicine Coalition, a US-based non-profit entity, reported that in 2023, the U.S. Food and Drug Administration (FDA) authorized 16 new personalized treatments for patients with rare diseases, marking a substantial rise from the six approved in 2022. Consequently, the increasing need for personalized medicine is projected to stimulate the expansion of the artificial intelligence clinical genomics interpretation market.
Artificial Intelligence Clinical Genomics Interpretation Market Segment Breakdown: Which Categories Lead On Revenue?
The artificial intelligence clinical genomics interpretation market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment Mode: Cloud Based, On Premises
3) By Application: Oncology, Rare Diseases, Pharmacogenomics, Infectious Diseases, Other Applications
4) By End User: Hospitals And Clinics, Research Institutes, Diagnostic Laboratories, Other End User
Subsegments:
1) By Software: Genomic Data Analysis, Variant Interpretation, Clinical Decision Support, Predictive Modeling, Reporting And Visualization
2) By Services: Implementation And Integration, Consulting And Advisory, Training And Support, Data Management, Maintenance And Upgrades
Artificial Intelligence Clinical Genomics Interpretation Market Innovation Trends: What Developments Are Reshaping The Industry?
Major companies in the artificial intelligence clinical genomics interpretation market are prioritizing innovations that improve scalability for large genomic studies, thereby enabling high-throughput data processing, enhancing the accuracy of genomic insights, and accelerating the discovery of biomarkers and therapeutic targets. Scalability refers to the ability of AI systems to efficiently process massive and intricate genomic datasets without compromising speed or precision, which is a vital requirement as sequencing volume and complexity continuously increase. For example, in December 2024, QIAGEN, a Germany-based life sciences company, launched an AI-powered extension for its Ingenuity Pathway Analysis (IPA) platform to automate the interpretation of complex biological data. This enhancement utilizes AI to identify key genes, pathways, and molecular networks involved in diseases, and integrates QIAGEN’s Biomedical Knowledge Base, containing hundreds of millions of AI-derived relationships, to support more accurate and data-driven insights.
Artificial Intelligence Clinical Genomics Interpretation Market Leading Players And Competitive Positioning
Major companies operating in the artificial intelligence clinical genomics interpretation market are F. Hoffmann-La Roche AG, NVIDIA Corporation, Illumina Inc., QIAGEN N.V., Tempus Labs Inc., GeneDx Inc., Freenome Inc., NantHealth Inc., SOPHiA GENETICS SA, Genomenon Inc., DNAnexus Inc., Lifebit Biotech Ltd., Deep Genomics Inc., SpeeDx Pty Ltd, PierianDx Inc., Genuity Science Inc., Karius Inc., FDNA Inc., SeqOne Genomics Inc., Nostos Genomics Inc.
View The Full Artificial Intelligence Clinical Genomics Interpretation Market Report:
Artificial Intelligence Clinical Genomics Interpretation Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the artificial intelligence clinical genomics interpretation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence clinical genomics interpretation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
